Abstract
Diabetic foot ulcers (DFUs) are common and constitute a considerable burden
for both patients and healthcare providers. Reducing the length of time to
healing reduces the risk of infection and further morbidity. Biofilms delay
healing, therefore, they should be treated with a biofilm-based wound care
regimen consisting of debridement, topical agents (antimicrobials and antiseptics)
and, if appropriate, systemic antibiotics (Cutting and Westgate, 2012). This
case series focuses on the use of octenilin®, which contains a broad-spectrum
antimicrobial, in the treatment of DFUs to address bioburden, prevent infection
and progress healing.
for both patients and healthcare providers. Reducing the length of time to
healing reduces the risk of infection and further morbidity. Biofilms delay
healing, therefore, they should be treated with a biofilm-based wound care
regimen consisting of debridement, topical agents (antimicrobials and antiseptics)
and, if appropriate, systemic antibiotics (Cutting and Westgate, 2012). This
case series focuses on the use of octenilin®, which contains a broad-spectrum
antimicrobial, in the treatment of DFUs to address bioburden, prevent infection
and progress healing.
| Original language | English |
|---|---|
| Pages (from-to) | 192-197 |
| Number of pages | 6 |
| Journal | The Diabetic Foot Journal |
| Volume | 21 |
| Issue number | 3 |
| Publication status | Published - 13 Sept 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Case studies: octenidine in the management of diabetic foot ulcers'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver